Physician Proponent: Prescription Solutions' Brian Solow, MD, talks physician-PBM relationship
The relationship between physicians and pharmacy benefit managers continues to change. A goal of Prescription Solutions' Brian Solow, MD, is to foster a collaborative approach to working with physicians, to ultimately deliver better care to patients.
During his tenure with Bristol Park Medical Group, a physician-owned primary care group in Irvine, he participated on multiple leadership committees while maintaining a family medicine practice. Over the years, Dr. Solow has gained knowledge of the PBM industry as a member of the national pharmacy and therapeutics committees of various PBMs.
"I reach out to doctors and find out how we can become their partners and not interfere with their practices," Dr. Solow says. "We need them to recognize the true value of the PBM because a lot of physicians just see PBMs as another piece of the insurance puzzle. We know we can target the consumer, and the consumer can target the doctor. If we can get both parties onboard, we'll have better success implementing medi cation therapy management [MTM] and other clinical programs."
Q. What is your biggest challenge with managing pharmaceutical benefits?
We want them to understand that we are not trying to limit their utilization of medications, nor are we trying to limit choices, but rather are promoting the appropriateness of their prescription medications with a focus on the clinical quality. It's important that all stakeholders in the healthcare system work together to help patients lead healthy, productive lives.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More
